Intraday Price Movement Analysis Nectar Lifescience witnessed severe selling pressure on 24 December 2025, as the stock plummeted to its… Continue Reading
Articles
Supriya Lifescience Stock Technical Analysis Report
Technical Trend Overview The technical trend for Supriya Lifescience has transitioned from a mildly bullish stance to a more pronounced… Continue Reading
Supriya Lifescience Targets Rs 1,600 Crore Revenue
Ambitious Revenue Growth Targets Supriya Lifescience is charting an aggressive growth trajectory, aiming to achieve revenues of up to Rs… Continue Reading
Life Sciences Embrace Non-Animal Testing Methods Era
Introduction: A Transformative Shift in Testing The life sciences industry stands at a critical juncture where the objective of advancing… Continue Reading
RPG LifeScience Stock Analysis and Market Outlook
Introduction The pharmaceutical sector continues to attract investor attention, with companies like RPG LifeScience demonstrating a complex mix of strengths… Continue Reading
Supriya Lifescience Targets Rs 1,600 Crore Revenue
Ambitious Revenue Growth Targets Mumbai-based Supriya Lifescience has outlined an aggressive expansion roadmap, targeting revenues of up to Rs 1,600… Continue Reading
CSIR NET Life Science December 2025 Analysis
Overview and Key Highlights Examination Date and Importance The CSIR NET December 2025 Life Science examination was conducted on 18… Continue Reading
Morgan Lewis Expands Life Sciences Practice Nationwide
Strategic Expansion in Life Sciences Sector Morgan Lewis & Bockius LLP continues its aggressive coast-to-coast expansion strategy by strengthening its… Continue Reading
ERIS Lifescience Stock Evaluation Revision Explained
Understanding the Market Assessment Shift The recent revision in ERIS Lifescience’s market evaluation reflects a comprehensive analysis across multiple dimensions… Continue Reading
Aristo Bio-Tech ROE Analysis Investment Insights
Understanding Aristo Bio-Tech’s Recent Performance Aristo Bio-Tech and Lifescience (NSE:ARISTO) has experienced a challenging quarter, with its stock declining 13%… Continue Reading